Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
October 29, 2025

Get In Touch

Koselugo approved in EU for plexiform neurofibromas in adults with neurofibromatosis type 1: AstraZeneca Pharma News

Koselugo approved in EU for plexiform neurofibromas in adults with neurofibromatosis type 1: AstraZeneca

  • 29 October 2025
  • 9 hours ago

AstraZeneca Koselugo recommended for approval in EU for plexiform neurofibromas in adults with neurofibromatosis type 1 Pharma News

AstraZeneca Koselugo recommended for approval in EU for plexiform neurofibromas in adults with neurofibromatosis type 1

  • 28 September 2025
  • 1 month ago

Selumetinib Effective, Safe In Kids With Symptomatic And Inoperable Plexiform Neurofibromas Pediatrics and Neonatology

Selumetinib Effective, Safe In Kids With Symptomatic And Inoperable Plexiform Neurofibromas

  • 22 July 2025
  • 3 months ago

Recent News

NEET counselling 2025: DME Gujarat further extends...

  • 29 October, 2025

Breaking News: Delhi HC Stays FSSAI Order On ORS L...

  • 29 October, 2025

MP FDA Moves Rs 320-Crore Proposal to CDSCO, FSSAI...

  • 29 October, 2025

Maha: Rs 14-Crore Mephedrone Unit Busted Near Poli...

  • 29 October, 2025

Pulse Pharma Gets CDSCO Panel Nod to Manufacture,...

  • 29 October, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.